January 27, 2006
FDA Won't Regulate 'IRB Shopping'
The Food and Drug Administration announced last week that it would not regulate "IRB shopping," a practice in which sponsors of clinical trials choose to submit proposed research to institutional review boards that they believe will approve it. The FDA said it had concluded that such choosiness either does not occur or is not a significant problem.
Many large universities and higher-education groups had criticized the idea of new rules, saying they would bog down institutional review
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
Research
-
Faculty
-
Advice
